Obese kidney transplant recipients have good outcomes

Transplant Proc. 2001 Nov-Dec;33(7-8):3420-1. doi: 10.1016/s0041-1345(01)02474-5.

Authors

R J Howard¹, V B Thai, P R Patton, A W Hemming, A I Reed, W J Van der Werf, S Fujita, J L Karlix, J C Scornik

Affiliation

¹ Department of Surgery, University of Florida College of Medicine, Gainesville, Florida 326100286, USA.

PMID: 11750464
DOI: 10.1016/s0041-1345(01)02474-5

No abstract available

MeSH terms

Adult
Azathioprine / therapeutic use
Body Mass Index
Cyclosporine / therapeutic use
Diabetes Mellitus / epidemiology
Drug Therapy, Combination
Family
Follow-Up Studies
Graft Survival
Humans
Immunosuppressive Agents / therapeutic use
Kidney Transplantation / mortality
Kidney Transplantation / physiology*
Living Donors
Obesity / physiopathology*
Postoperative Complications / epidemiology
Prednisone / therapeutic use
Retrospective Studies
Survival Rate
Time Factors
Tissue Donors
Treatment Outcome

Substances

Immunosuppressive Agents
Cyclosporine
Azathioprine
Prednisone